Loading data for MSB — first visit, this takes a few seconds.

Mesabi Trust (MSB)

NYSE: MSB · 即時價格 · USD

24.59

+0.13 (0.53%)

收盤價： Sep 02, 2026, 3:59 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

0.51% (1D)

買價	24.35
市值	323M
營收 (ttm)	15M
淨利（ttm）	11.3M
	0.33
	0.86
	28.63
	-1.24
P/B (ttm)	17.61
P/S (ttm)	21.48
財報日期	n/a

賣價	24.82
成交量	6,512
20 日平均成交量	39,866
開盤價	24.36
前收盤價	24.46
當日區間	24.06 - 24.67
52 週範圍	21.60 - 42.38
分析師	n/a
目標價	n/a
股利	$0.89 (3.60%)
除息日	Jul 30, 2026

關於 MSB

Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was incorporated in 1961 and is based in New York, New York....

[閱讀更多]

產業 Steel

類股 Basic Materials

IPO 日期 Feb 21, 1973

員工 n/a

證券交易所 NYSE

股票代號 MSB

網站 https://mesabi-trust.com

完整的公司簡介

財務表現

Mesabi Trust 在 2026 年的營收為 16.57M，較前一年的 25.46M 減少 -34.91%。淨利為 13.87M，較前期減少 -85.13%。

財務報表

財報驚奇

Mesabi Trust 已於 Apr 10, 2013 公布季度財報：

營收為 $2.08M 低於預期 $0, 年增 -52.23% 下滑.
每股盈餘為 0.36 低於預期 -0.06, 年增 -25.00% 下滑.

價格為何變動

新聞動態

4 月前 · Simply Wall St.

Assessing Cleveland-Cliffs (CLF) Valuation After Mesabi Trust Distribution Cut Highlights Operational Uncertainty

Mesabi Trust’s decision to cut its distribution, after receiving lower royalty payments from Cleveland-Cliffs (CLF), has drawn fresh attention to uncertainties around the miner’s Northshore iron ore o...

4 月前 · Simply Wall St.

ASX April 2026 Stocks Estimated To Be Trading Below Fair Value

The Australian stock market is experiencing a period of optimism, with the ASX 200 futures seeing a significant rise as global equities receive a boost from renewed geopolitical negotiations. Amidst t...

4 月前 · Simply Wall St.

Gregory George Adds To Mesoblast Position With Multi-Market Share Purchases

Mesoblast Limited ( ASX:MSB ) shareholders (or potential shareholders) will be happy to see that insider Gregory George...

4 月前 · Simply Wall St.

Mesoblast (ASX:MSB) Is Down 11.0% After FDA Clears Registrational DMD Trial For Ryoncil - Has The Bull Case Changed?

Mesoblast recently announced that the US FDA has granted Investigational New Drug clearance to move directly into a registrational clinical trial of Ryoncil in children with Duchenne muscular dystroph...

4 月前 · Simply Wall St.

Is Mesoblast (ASX:MSB) Price Swings Creating A Possible Valuation Opportunity?

If you are wondering whether Mesoblast at around A$2.02 is still priced attractively or already reflecting high expectations, the valuation story matters more than ever. The share price has seen mixed...

第 1 頁，共 2 頁

Mesabi Trust (MSB)

Mesabi Trust（MSB）股價、分析與資料

關於 MSB

財務表現

財報驚奇

價格為何變動

新聞動態

4 月前 · Simply Wall St.

4 月前 · Simply Wall St.

4 月前 · Simply Wall St.

4 月前 · Simply Wall St.

4 月前 · Simply Wall St.